Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeremy Rosenblum
Combining Dinutuximab With ALT-803 (IL-15 Superagonist) Significantly Improves the Activity of Ex Vivo Expanded Natural Killer Cells Against GD2 + Pediatric Solid Tumors (ST)
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Improving Microbiological Diagnostic Yield of Bronchoalveolar Lavage (BAL) Specimens in Pediatric Allogeneic Hematopoietic Stem Cell Transplant (AlloHSCT) Recipients
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Related publications
Enhancing the Functional Activity of Natural Killer Cells Against Myeloid Leukemia With the IL-15 Super-Agonist, ALT-803
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Combining ROR1- Specific Chimeric Antigen Receptor (CAR) NK Cells With IL-15 Superagonist (N-803/Alt-803) to Target Chemotherapy Resistant Neuroblastoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
The IL-15 Superagonist ALT-803 Enhances Anti-Cd20 Antibody-Directed NK Cell ADCC and in Vivo Clearance of B Cell Lymphomas
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation in Vivo in High-Risk Relapsed Multiple Myeloma Patients
Journal of immunotherapy (Hagerstown, Md. : 1997)
Cancer Research
Allergy
Immunology
Pharmacology
IL-15 Availability Conditions Homeostasis of Peripheral Natural Killer T Cells
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models
Cancer immunology research
Cancer Research
Immunology
Evaluating Natural Killer Cell Cytotoxicity Against Solid Tumors Using a Microfluidic Model
OncoImmunology
Oncology
Allergy
Immunology
Correction To: IL-27 Enhances IL-15/IL-18-mediated Activation of Human Natural Killer Cells
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-Cd73 Axis in Solid Tumors
Frontiers in Molecular Biosciences
Biochemistry
Genetics
Molecular Biology
